Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Current Assets (2019 - 2025)

Historic Current Assets for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $802.7 million.

  • IDEAYA Biosciences' Current Assets fell 1389.8% to $802.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $802.7 million, marking a year-over-year decrease of 1389.8%. This contributed to the annual value of $689.7 million for FY2024, which is 2949.15% up from last year.
  • As of Q3 2025, IDEAYA Biosciences' Current Assets stood at $802.7 million, which was down 1389.8% from $685.6 million recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Current Assets registered a high of $932.2 million during Q3 2024, and its lowest value of $251.0 million during Q4 2021.
  • Its 5-year average for Current Assets is $500.1 million, with a median of $482.2 million in 2023.
  • As far as peak fluctuations go, IDEAYA Biosciences' Current Assets skyrocketed by 24444.92% in 2021, and later plummeted by 1690.98% in 2022.
  • Over the past 5 years, IDEAYA Biosciences' Current Assets (Quarter) stood at $251.0 million in 2021, then surged by 47.59% to $370.5 million in 2022, then soared by 43.78% to $532.6 million in 2023, then rose by 29.49% to $689.7 million in 2024, then increased by 16.38% to $802.7 million in 2025.
  • Its Current Assets stands at $802.7 million for Q3 2025, versus $685.6 million for Q2 2025 and $707.9 million for Q1 2025.